Home
>
National Drug Code (NDC)
>
Revatio
Revatio - 0069-0338-01 - (sildenafil citrate)
Drug Information of Revatio
| Product NDC: | 0069-0338 |
| Proprietary Name: | Revatio |
| Non Proprietary Name: | sildenafil citrate |
| Active Ingredient(s): | .8 mg/mL & nbsp; sildenafil citrate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Revatio
| Product NDC: | 0069-0338 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022473 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20091118 |
Package Information of Revatio
| Package NDC: | 0069-0338-01 |
| Package Description: | 12.5 mL in 1 VIAL, SINGLE-USE (0069-0338-01) |
NDC Information of Revatio
| NDC Code | 0069-0338-01 |
| Proprietary Name | Revatio |
| Package Description | 12.5 mL in 1 VIAL, SINGLE-USE (0069-0338-01) |
| Product NDC | 0069-0338 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sildenafil citrate |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20091118 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | SILDENAFIL CITRATE |
| Strength Number | .8 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
